12/16/17 Clinical Support for Implementation of Buprenorphine Training Registration: Long Island |
Clinical Support for Implementation of Buprenorphine
When: Saturday, December 16th, 2017, 9:30AM - 12:30PM
The NYSDOH AIDS Institute is sponsoring a new, free training on Clinical Support for Implementation of Buprenorphine. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder (OUD) is urgently needed.
*Have you completed all required training to obtain a buprenorphine waiver? Do you have your waiver or plan to obtain your waiver but are looking for clinical support on how to start prescribing and providing buprenorphine with your patients?* This training is for Physicians, Nurse Practitioners, and Physician Assistants whom have completed all required waiver training and would like to learn best practices, obtain technical assistance, and/or implement and provide buprenorphine for patients with OUD in various practice settings.
Decades of research has shown that medication-assisted treatment (MAT) with buprenorphine or methadone is the most effective treatment for those with OUD. Overall, individuals who are opioid dependent and receive MAT have less than half the risk of dying compared to those who do not receive it. Buprenorphine is the first medication approved to treat opioid dependence in a primary care setting. This training will provide clinicians with information about how to treat patients with OUD using buprenorphine that is evidence-based and informed by the principles of harm reduction and public health. This training is intended to increase buprenorphine waived providers to start prescribing and/or increase the number of patients they prescribe to. Providers will have opportunities to share best practices and challenges with one another in order to share in the learning experience and build relationships.
*Have you completed all required training to obtain a buprenorphine waiver? Do you have your waiver or plan to obtain your waiver but are looking for clinical support on how to start prescribing and providing buprenorphine with your patients?* This training is for Physicians, Nurse Practitioners, and Physician Assistants whom have completed all required waiver training and would like to learn best practices, obtain technical assistance, and/or implement and provide buprenorphine for patients with OUD in various practice settings.
Decades of research has shown that medication-assisted treatment (MAT) with buprenorphine or methadone is the most effective treatment for those with OUD. Overall, individuals who are opioid dependent and receive MAT have less than half the risk of dying compared to those who do not receive it. Buprenorphine is the first medication approved to treat opioid dependence in a primary care setting. This training will provide clinicians with information about how to treat patients with OUD using buprenorphine that is evidence-based and informed by the principles of harm reduction and public health. This training is intended to increase buprenorphine waived providers to start prescribing and/or increase the number of patients they prescribe to. Providers will have opportunities to share best practices and challenges with one another in order to share in the learning experience and build relationships.
Trainers:
Bruce Trigg, MD, Harm Reduction Coalition, New York, NY
Kelly Ramsey, MD, Hudson River Healthcare, Poughkeepsie, NY & Suffolk County Locations
Kelly Ramsey, MD, Hudson River Healthcare, Poughkeepsie, NY & Suffolk County Locations
Where:
Hilton Garden Inn Stony Brook, 1 Circle Road, Shirley Kenny Room, Stony Brook, NY 11794
Directions: https://goo.gl/maps/MuGgFx6ZTA42
*Space is limited so register fast!*
Questions:
NYSDOH, AIDS Institute, Office of Drug User Health
Stephen Crowe, 212-417-4558, stephen.crowe@health.ny.gov
Lyla Hunt, 518-473-7428, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in partnership with the Harm Reduction Coalition.
Lyla Hunt, 518-473-7428, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in partnership with the Harm Reduction Coalition.